SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-089162
Filing Date
2020-07-31
Accepted
2020-07-31 17:15:28
Documents
13
Period of Report
2020-07-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2026209d1_8k.htm   iXBRL 8-K 32074
2 EXHIBIT 99.1 tm2026209d1_ex99-1.htm EX-99.1 432394
  Complete submission text file 0001104659-20-089162.txt   663404

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akrx-20200731.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20200731_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20200731_pre.xml EX-101.PRE 22706
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2026209d1_8k_htm.xml XML 3488
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 201066876
SIC: 2834 Pharmaceutical Preparations